Gathering life energy
Caring for human health

OEC    Mail    |

搜索
Search
Stock Code:603520
Check category
/
/
/
Peng Xijun, general manager of Shanghai New Jinshan Industrial Investment and Development Co., Ltd., and his delegation visited our company

Peng Xijun, general manager of Shanghai New Jinshan Industrial Investment and Development Co., Ltd., and his delegation visited our company

  • Categories:Company news
  • Author:Shengwei Xiang
  • Origin:
  • Time of issue:2021-01-07
  • Views:0

(Summary description)On January 7th, Peng Xijun, general manager of Shanghai New Jinshan Industrial Investment and Development Co., Ltd. and his party visited our company for investigation and guidance.

Peng Xijun, general manager of Shanghai New Jinshan Industrial Investment and Development Co., Ltd., and his delegation visited our company

(Summary description)On January 7th, Peng Xijun, general manager of Shanghai New Jinshan Industrial Investment and Development Co., Ltd. and his party visited our company for investigation and guidance.

  • Categories:Company news
  • Author:Shengwei Xiang
  • Origin:
  • Time of issue:2021-01-07
  • Views:0
Information
On January 7th, Peng Xijun, general manager of Shanghai New Jinshan Industrial Investment and Development Co., Ltd. and his party visited our company for investigation and guidance.
 
At the meeting, Hu Jinsheng, the chairman of the company, introduced to Peng Xijun and his party the company's operating status, development history, product layout, subsidiaries and R & D registration and other aspects. Hu said that during the CoviD-19 epidemic, the use of contrast agents increased significantly, and people will become more aware of their own health problems in the future. Hu Jinsheng also focused on reporting the pharmaceutical products of Shanghai Staili Pharmaceutical Co., Ltd. He said iodine, alcohol injection and alcohol alcohol injection and iodine iodine sea sand injection products such as the first through the national new 4 class registration (as by "consistency" drug evaluation, namely the national requirements of generic drugs to be in line with the original drug quality and curative effect, uniform, stability, uniform, including impurities dissolution laws) in vivo and in vitro, fill in the company too pharmaceutical industry chain in the preparation of blank, the company successfully completed from API to the preparation of industrial transformation and upgrading, eight years, we have to plum blossom incense, this is a major milestone in the development of the company; The company's pharmaceutical products to carry out competition with foreign original research units, effectively adjust the drug price, let the domestic people look up to the disease, for the common people's health to make contributions.
 
After listening to Hu Jinsheng's report, Peng Xijun gave great recognition to the company's main products and production and operation. Peng Xijun pointed out that the biomedical industry is a strategic emerging industry. After more than 20 years of development, Staili has achieved fruitful results and made great contributions to the local economic development. Staili company has a sound, perfect management system, management ideas; The company's products will be able to stand firm in the international market, hope that the future development of Stellis to a higher level. After the meeting, Peng Xijun and his delegation also visited the Hall of Honor of the company.
 

Scan the QR code to read on your phone